The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia (Q60403662)
Jump to navigation
Jump to search
scientific article published on 01 May 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia |
scientific article published on 01 May 2007 |
Statements
The AP-1/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia (English)
Rodrigo Moore-Carrasco
Vanessa Almendro
Moorthy Palanki
Francisco J López-Soriano
Josep M Argilés